Sanofi's next-generation insulin shows edge over Lantus

PARIS (Reuters) - An improved version of Sanofi's blockbuster insulin Lantus is better than the older drug at controlling blood sugar lows at night, a common side effect in diabetics treated with insulin, according two late-stage tests published on Saturday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news